Looking ahead to 2030, our model projects INCY could trade at an average price of $166.41, with a potential range between $124.81 and $208.01. This represents a potential 40.0% return from today's ...
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and ...
Incyte Corp. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of proprietary therapeutics. It focuses on hematology and oncology, and inflammation and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results